Your browser doesn't support javascript.
loading
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.
de Boer, Nadine Leonie; Brandt-Kerkhof, Alexandra R M; Madsen, Eva V E; Diepeveen, Marjolein; van Meerten, Esther; van Eerden, Ruben A G; de Man, Femke M; Bouamar, Rachida; Koolen, Stijn L W; de Hingh, Ignace H J T; Bakkers, Checca; Rovers, Koen P; Creemers, Geert-Jan M; Deenen, Maarten J; Kranenburg, Onno W; Constantinides, Alexander; Mathijssen, Ron H J; Verhoef, Cornelis; Burger, Jacobus W A.
Afiliación
  • de Boer NL; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Brandt-Kerkhof ARM; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Madsen EVE; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Diepeveen M; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Bouamar R; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands.
  • Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • de Hingh IHJT; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands.
  • Bakkers C; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
  • Rovers KP; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
  • Creemers GM; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
  • Deenen MJ; Department of Medical Oncology, Catharina Cancer Institute, Eindhoven, The Netherlands.
  • Kranenburg OW; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.
  • Constantinides A; Department of Surgical Oncology and Utrecht Platform for Organoid Technology, UMC Utrecht Cancer Centre, Utrecht, The Netherlands.
  • Mathijssen RHJ; Department of Surgical Oncology and Utrecht Platform for Organoid Technology, UMC Utrecht Cancer Centre, Utrecht, The Netherlands.
  • Verhoef C; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Burger JWA; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
BMJ Open ; 9(12): e034508, 2019 12 08.
Article en En | MEDLINE | ID: mdl-31818845

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Proyectos de Investigación / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Estudios Multicéntricos como Asunto / Ensayos Clínicos Fase I como Asunto / Irinotecán Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Proyectos de Investigación / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Estudios Multicéntricos como Asunto / Ensayos Clínicos Fase I como Asunto / Irinotecán Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos